ArticleFrontiers in oncology2021

Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients.

MinMing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.